In this thought leader article Orjana Terova, Melisa Carpio, Ian Flaherty, Robin Butler, Nico Tuason, and Christine Gebski from Repligen describe how disruptive technologies are improving efficiency ...
OXB collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated ...
11d
SkyQuest projects that the Global Gene Therapy Market will reach a value of USD 38.34 Billion by 2031, with a CAGR of 19% during the forecast period (2024-2031).Numerous factors are responsible for ...
ERK5 suppression overcomes FAK inhibitor resistance in mutant KRAS-driven non-small cell lung cancer
The inhibition of ERK5 is a potential complementary strategy for countering FAK inhibitor resistance in patients with lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback